| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10008555 | HBV | ENSG00000145451.13 | protein_coding | GLRA3 | No | No | 8001 | O75311 Q9UPF3 |
| TVIS10007636 | HBV | ENSG00000145451.13 | protein_coding | GLRA3 | No | No | 8001 | O75311 Q9UPF3 |
| TVIS30013278 | HIV | ENSG00000145451.13 | protein_coding | GLRA3 | No | No | 8001 | O75311 Q9UPF3 |
| TVIS30061554 | HIV | ENSG00000145451.13 | protein_coding | GLRA3 | No | No | 8001 | O75311 Q9UPF3 |
| TVIS30061555 | HIV | ENSG00000145451.13 | protein_coding | GLRA3 | No | No | 8001 | O75311 Q9UPF3 |
| TVIS30061556 | HIV | ENSG00000145451.13 | protein_coding | GLRA3 | No | No | 8001 | O75311 Q9UPF3 |
| TVIS20031922 | HPV | ENSG00000145451.13 | protein_coding | GLRA3 | No | No | 8001 | O75311 Q9UPF3 |
| TVIS20058819 | HPV | ENSG00000145451.13 | protein_coding | GLRA3 | No | No | 8001 | O75311 Q9UPF3 |
| TVIS20019109 | HPV | ENSG00000145451.13 | protein_coding | GLRA3 | No | No | 8001 | O75311 Q9UPF3 |
| TVIS20033119 | HPV | ENSG00000145451.13 | protein_coding | GLRA3 | No | No | 8001 | O75311 Q9UPF3 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GLRA3 |
|---|---|
| DrugBank ID | DB00145 |
| Drug Name | Glycine |
| Target ID | BE0000414 |
| UniProt ID | O75311 |
| Regulation Type | ligand |
| PubMed IDs | 17154252; 17550639 |
| Citations | Heinze L, Harvey RJ, Haverkamp S, Wassle H: Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit. J Comp Neurol. 2007 Feb 1;500(4):693-707.@@Majumdar S, Heinze L, Haverkamp S, Ivanova E, Wassle H: Glycine receptors of A-type ganglion cells of the mouse retina. Vis Neurosci. 2007 Jul-Aug;24(4):471-87. Epub 2007 May 29. |
| Groups | Approved; Nutraceutical; Vet_approved |
| Direct Classification | Alpha amino acids |
| SMILES | NCC(O)=O |
| Pathways | gamma-Glutamyltranspeptidase Deficiency; Lesch-Nyhan Syndrome (LNS); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Molybdenum Cofactor Deficiency; AICA-Ribosiduria; Purine Nucleoside Phosphorylase Deficiency; gamma-Glutamyltransferase Deficiency; Hyperprolinemia Type II; Glutamate Metabolism; Adenine Phosphoribosyltransferase Deficiency (APRT); Mercaptopurine Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); L-Arginine:Glycine Amidinotransferase Deficiency; Hyperinsulinism-Hyperammonemia Syndrome; Congenital Bile Acid Synthesis Defect Type II; Porphyrin Metabolism; Prolidase Deficiency (PD); Glycine and Serine Metabolism; Carnitine Synthesis; Adenosine Deaminase Deficiency; Methionine Metabolism; Bile Acid Biosynthesis; Hyperprolinemia Type I; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; 27-Hydroxylase Deficiency; Sarcosine Oncometabolite Pathway; Purine Metabolism; Gout or Kelley-Seegmiller Syndrome; Ammonia Recycling |
| PharmGKB | PA449789 |
| ChEMBL | CHEMBL773 |
